COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,788 Articles (22,946 medRxiv, 8,842 bioRxiv)

Most recent first Previous |  Page 3: Articles 21-30  | Next

Accelerated discovery of thermostable vaccines using data-efficient AI
Tian, J., Tran, K. T. M., Pogostin, B. H., Sheridan, O., Mursalova, S., Lee, A. H., Liu, S., Hamkins, J., Antov, D., Power, A. L., Dash, Z. S., Yun, D., Konakovic Lukovic, M., Langer, R., Jaklenec, A.
10.64898/2026.09.17.752370 — Posted: 2026-09-18
Hantaan virus polymerase has an in vitro Terminal Nucleotidyl Transferase activity that is conserved across the Bunyaviricetes class
Barata-Garcia, S., Durieux Trouilleton, Q., Debarnot, C., MALET, H., Reguera, J.
10.64898/2026.09.16.751791 — Posted: 2026-09-18
Transmission of mutated SARS-CoV-2 variants is favored by relatively prolonged infections due to delayed immunity
Owens, K., Radecki, P., Tempia, S., von Gottberg, A., Cohen, C., Boritz, E., Schiffer, J. T., Reeves, D. B.
10.64898/2026.09.15.751875 — Posted: 2026-09-18
Durability and diversity of human upper airway T cell memory
Ramirez, S. I., Faraji, F., Lopez, P. G., Garin-Ortega, L., Hern, N. A., Eisenman, O., Azhan, A., Frazier, A., Phillips, E. J., Mallal, S., Sette, A., Dileepan, T., Jenkins, M. K., Crotty, S.
10.64898/2026.09.15.751278 — Posted: 2026-09-18
3D Spatial Interactomics Maps the Dynamics of NF-κB Multiprotein Signalosomes in Single Cells
Zhang, N., Leese-Thompson, C., Ozuna, H., Peng, B., Sirigireddy, S., Nambiar, D., Ramanan, L., Tirouvanziam, R., Kopp, B., Coskun, A. F.
10.64898/2026.09.14.751198 — Posted: 2026-09-17
The selection for cidofovir-resistant mutant vaccinia viruses is inhibited by coinfecting cidofovir-sensitive wildtypes
Lee, S. Z., Lin, Y.-C., Evans, D. H., Noyce, R. S.
10.64898/2026.09.14.751616 — Posted: 2026-09-17
Risk factors and immunological characteristics of SARS-CoV-2 RNA re-positivity in convalescent COVID-19 Patients: A retrospective study
Li, L., Zhang, X., Fan, J., Fan, J., Du, J., Yan, H., Dai, E., Gao, H., Feng, A.
10.64898/2026.09.11.750839 — Posted: 2026-09-17
Cost-Effectiveness of Ensitrelvir for COVID-19 Post-Exposure Prophylaxis Among High-Risk Household Contacts in Japan: A Model-Based Cost-Utility Analysis
Taniguchi, T., Yahaba, M., Yoshikawa, H., Igari, H., Sato, D.
10.64898/2026.09.15.26361876 — Posted: 2026-09-16
Structural basis of diverse antibody recognition of conserved coronavirus spike S2 epitopes that contribute to protective immunity
Rubio, A. A., Crivelli, V., Hönig, V., Cizkova, M., Cervantes Rincon, T., Abernathy, M. E., Parada, M. K., Vahdat, D., Lee, Y. E., Eso, M., Cantergiani, J., Moro, S. G., Jarrossay, D., Guerra, C., Cena, B., Minculescu, M., Gradauskaite, V., Biggiogero, M., Calvaruso, V., Pellanda, A. F., Cavalli, A., Garzoni, C., Palus, M., Robbiani, D. F., Barnes, C. O.
10.64898/2026.09.13.750764 — Posted: 2026-09-16
Effectiveness of 2025 bi-annual COVID-19 vaccination campaigns against hospitalisation in England
Abdul Aziz, N., Allen, A., Andrews, N.
10.64898/2026.09.14.26362989 — Posted: 2026-09-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).